3xTg-AD mice transferred with Aβ+ Tregs when as young as 3 months of age displayed significant reductions in the levels of Aβ aggregates (Figure 3G) and phosphorylated tau (Figure 3H) compared with those in 3xTg-AD mice. This evidence concerns the gene MAPT and Alzheimer disease.